Guidant Champion Stent Design Flaw Delays Marketing By Up To Eight Months
This article was originally published in The Gray Sheet
Executive Summary
A European launch of Guidant's Champion everolimus drug-eluting stent will require no additional clinical data, despite needed design and manufacturing changes, the firm says